GV1001 Reprograms CD47 Immune Checkpoint to Restore Macrophage Antitumor Activity in Oral Squamous Cell CarcinomaWei Chen(University of California, Los Angeles), No-Hee Park(University of California, Los Angeles)International Journal of Molecular SciencesApril 7, 202610.3390/ijms27073340Cited by 0SaveCiteExport RISWatch citationsRelated PapersGV1001, an hTERT-Derived Peptide, Prevents Cisplatin-Induced Nephrotoxicity by Preserving Mitochondrial Function|Preprints.org|2025|1